Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer: a Comparative Randomized Phase II Trial

NCT03777813 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT03777813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03777813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer: a Comparative Randomized Phase II Trial
Lead sponsor
UNICANCER
Phase
Phase 2
Overall status
Completed
Start date
December 5, 2018
Completion date
December 1, 2024
Enrollment
112 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

esophagus cancer, unresectable malignant neoplasm